Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $35 from $30 and keeps an Outperform rating on the shares. American Healthcare’s Q4 core FFO miss vs. the firm’s estimate was primarily related to dispositions and ATM activity, while the integrated senior health campuses and senior housing operating property segments saw “exceptional” growth during the quarter, the analyst tells investors in a research note. American Healthcare REIT is uniquely positioned to outperform over the foreseeable future given its exposure to senior housing REIT Investment Diversification and Empowerment Act assets, which carries some of the best fundamentals in real estate, the firm says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- 3 Best Stocks to Buy Now, 3/3/2025, According to Top Analysts
- American Healthcare REIT: Strong Financial Performance and Strategic Acquisitions Justify Buy Rating
- American Healthcare REIT Reports 2024 Results and 2025 Outlook
- American Healthcare REIT’s Earnings Call Highlights Strong Growth
- American Healthcare REIT Reports 2024 Financial Results